Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who are at least one year of age.~* Subjects who have a clinical diagnosis of acute bacterial conjunctivitis.~* Subjects who are willing to discontinue contact lens wear for the duration of the study.~Exclusion Criteria:~* Subjects who have any uncontrolled systemic disease or debilitating disease.~* Subjects with known sensitivity or contraindications to besifloxacin, fluoroquinolones or any ingredients in study drugs.~* Subjects who are expected to require treatment with any disallowed medications.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Besifloxacin (Type: EXPERIMENTAL): 0.6% ophthalmic suspension
- Vehicle (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).